Related Experiment Video
Updated: Jul 17, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop
Anne Marie Comeau1, Frank J Accurso, Terry B White
1New England Newborn Screening Program and Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Insights
Implementing cystic fibrosis newborn screening requires careful planning. Early detection through high-quality screening programs improves outcomes for infants with cystic fibrosis.
Area of Science:
- Medical Genetics
- Public Health
- Pediatrics
Background:
- Newborn screening for cystic fibrosis (CF) enables early intervention, potentially improving long-term health outcomes.
- The Cystic Fibrosis Foundation convened a workshop to guide the implementation of high-quality, widespread CF newborn screening programs.
Purpose of the Study:
- To outline essential steps for successful cystic fibrosis newborn screening implementation.
- To provide guidelines and resources for developing and executing effective screening protocols.
Main Methods:
- Formation of a dedicated workgroup including state newborn screening program directors and CF care center directors.
- Development of a tailored screening algorithm considering program resources, demographics, and disease spectrum.
- Ensuring availability of educational materials, diagnostic testing, counseling, and care protocols prior to launch.
Main Results:
- Successful implementation necessitates a comprehensive approach, from initial planning to ongoing care.
- Consideration of various screening algorithms and management of complex diagnostic results is crucial.
- Existing program experiences inform best practices for quality assurance and program success.
Conclusions:
- High-quality cystic fibrosis newborn screening requires collaborative planning and robust infrastructure.
- Early detection and intervention are key to improving outcomes for infants diagnosed with CF.
- Standardized guidelines and resources are vital for consistent and effective newborn screening programs.
Abstract:
Newborn screening for cystic fibrosis offers the opportunity for early intervention and improved outcomes. This summary, resulting from a workshop sponsored by the Cystic Fibrosis Foundation to facilitate implementation of widespread high quality cystic fibrosis newborn screening, outlines the steps necessary for success based on the experience of existing programs. Planning should begin with a workgroup composed of those who will be responsible for the success of the local program, typically including the state newborn screening program director and cystic fibrosis care center directors. The workgroup must develop a screening algorithm based on program resources and goals including mechanisms available for sample collection, regional demographics, the spectrum of cystic fibrosis disease to be detected, and acceptable failure rates of the screen. The workgroup must also ensure that all necessary guidelines and resources for screening, diagnosis, and care be in place prior to cystic fibrosis newborn screening implementation. These include educational materials for parents and primary care providers; systems for screening and for providing diagnostic testing and counseling for screen-positive infants and their families; and protocols for care of this unique population. This summary explores the benefits and risks of various screening algorithms, including complex situations that can occur involving unclear diagnostic results, and provides guidelines and sample materials for state newborn screening programs to develop and implement high quality screening for cystic fibrosis.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

